Velo3D, Inc. ((VLD) (the “Company” or “Velo3D”), a leading metal additive manufacturing technology company for mission-critical parts, today announced that its board of directors has approved a 1-for-35 reverse stock split of the Company’s common stock. The common stock will open for trading on the New York Stock Exchange (“NYSE”) on Thursday, June 13, 2024, on a split-adjusted basis under the current trading symbol “VLD”. In connection with the reverse stock split, the CUSIP numbers for the Company’s common stock will change to 92259N 203. The reverse stock split is intended to enable Velo3D to regain compliance with the minimum share price required for continued listing on NYSE. The reverse stock split was approved by Velo3D’s stockholders on June 10, 2024, with the final ratio determined by the Company’s board of directors on June 10, 2024.
Monte Rosa Therapeutics Q2 EPS $(0.57) Up From $(3.63) YoY
Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.57) per share. This is a 84.3 percent increase over losses of $(3.63) per share from the same period last year.
